SCHEDULE: PAVmed Inc. Stakeholder Discloses Significant Shareholding

Scopia Holdings LLC and Matthew Sirovich report beneficial ownership of 9.9% of PAVmed Inc. common stock, totaling 637,670 shares.

Summary

• Scopia Holdings LLC and Matthew Sirovich have filed a Schedule 13G, indicating their beneficial ownership of PAVmed Inc. common stock.
• Scopia Holdings LLC beneficially owns 630,118 shares.
• Matthew Sirovich may be deemed to beneficially own the shares held by Scopia Holdings LLC, and additionally owns 7,552 shares directly.
• The total aggregate amount beneficially owned by Matthew Sirovich is 637,670 shares.
• This represents 9.9% of the class of securities for Matthew Sirovich and 9.87% for Scopia Holdings LLC.
• Both reporting persons have sole voting power and sole dispositive power over their respective shares.
• The filing is made under Rule 13d-1(b) of the Securities Exchange Act of 1934.
• The reporting persons certify that the securities were not acquired or held for the purpose of influencing or changing the control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of shareholding and does not inherently signal positive or negative developments for the company.

Positives

• Significant stake reported by Scopia Holdings LLC and Matthew Sirovich, potentially indicating confidence in PAVmed Inc.'s future.
• Clear disclosure of beneficial ownership and voting/dispositive power.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to disclose their holdings in publicly traded companies. This filing indicates a substantial passive investment in PAVmed Inc. by Scopia Holdings LLC and Matthew Sirovich.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant shareholder's stake, which can influence market perception and trading activity.
• Management: The filing informs management of a substantial beneficial owner, potentially impacting strategic discussions and corporate governance considerations.

Key Dates

Keywords

PAVmed Inc., Schedule 13G, Scopia Holdings LLC, Matthew Sirovich, Beneficial Ownership, Common Stock, Securities Exchange Act, Shareholder Filing